Aminoguanidine - Effects on endoneurial vasoactive nitric oxide and on motor nerve conduction velocity in control and streptozotocin-diabetic rats

British Journal of Pharmacology

Volumn 120, Issue 4, 1997, Pages 593-598

  Dewhurst, M ^a   Omawari, N ^a   Tomlinson, D R ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Aminoguanidine; Blood flow; Diabetes mellitus; Diabetic neuropathy; L arginine; L NAME; Laser Doppler; Nerve conduction; Nitric oxide; Streptozotocin; Velocity

Indexed keywords

AMINOGUANIDINE; ARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CONTROLLED STUDY; DRUG EFFECT; ENDONEURIUM; LASER DOPPLER FLOWMETRY; MALE; MOTOR NERVE CONDUCTION; NONHUMAN; ORAL DRUG ADMINISTRATION; PERIPHERAL NERVE; PRIORITY JOURNAL; RAT; SCIATIC NERVE; STREPTOZOCIN DIABETES;

AMINE OXIDASE (COPPER-CONTAINING); ANIMALS; ARGININE; BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; ENZYME INHIBITORS; GUANIDINES; HEART RATE; LASER-DOPPLER FLOWMETRY; MALE; NEURAL CONDUCTION; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; RATS; RATS, WISTAR; SCIATIC NERVE; STREPTOZOCIN;

EID: 0031039865     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0700946     Document Type: Article

References (37)

1. BAYLIN, S., HORAKOVA, Z. & BEAVEN, M.A. (1975). Increase in food consumption and growth after treatment with aminoguanidine. Experientia, 31, 562-564.
2. BROWNLEE, M., VLASSARA, H., KOONEY, A., ULRICH, P. & CERAMI, A. (1986). Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science, 232, 1629-1632.
3. BUCALA, R., TRACEY, K.J. & CERAMI, A. (1991). Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J. Clin. Invest., 87, 432-438.
4. CAMERON, N.E., COTTER, M.A., DINES, K. & LOVE, A. (1992). Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats. Diabetologia, 35, 946-950.
5. CAMERON, N.E., COTTER, M.A., DINES, K.C. & MAXFIELD, E.K. (1993). Pharmacological manipulation of vascular endothelium function in non-diabetic and streptozotocin-diabetic rats: Effects on nerve conduction, hypoxic resistance and endoneurial capillarization. Diabetologia, 36, 516-522.
6. +-ATPase activity, and vascular supply in STZ-D rats. Diabetes, 40, 1652-1658.
7. DAY, T.J., LAGERLUND, T.D. & LOW, P.A. (1989). Analysis of H2 clearance curves used to measure blood flow in rat sciatic nerve. J. Physiol., 414, 35-54.
8. DEWHURST, M., STEVENS, E.J., KARASU, C. & TOMLINSON, D.R. (1994). Effects of aminoguanidine treatment on sciatic nerve laser Doppler flux and prostacyclin release from vascular tissues and sciatic nerve of control and streptozotocin-diabetic rats. Br. J. Pharmacol., 112, 373P.
9. GARDINER, S.M., KEMP, P.A., MARCH. J.E. & BENNETT, T. (1996). Influence of aminoguanidine and the endothelin antagonist, SB 209670, on the regional haemodynamic effects of endotoxaemia in conscious rats. Br. J. Pharmacol., 118, 1822-1828.
10. GRAVES, J. & POSTON, L. (1993). Beta-adrenoceptor agonist mediated relaxation of rat isolated resistance arteries: a role for the endothelium and nitric oxide. Br. J. Pharmacol., 108, 631-637.
11. HATTORI, Y., KAWASAKI, H., ABE, K. & KANNO, M. (1991). Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta. Am. J. Physiol., 261, H1086-H1094.
12. HILL, M.A. & EGE, E.A. (1994). Active and passive mechanical properties of isolated arterioles from STZ-induced diabetic rats. Effect of aminoguanidine treatment. Diabetes, 43, 1450-1456.
13. HUIJBERTS, M.S.P., WOLFFENBUTTEL, B.H.R., BOUDIER, H.A.J.S., CRIJNS, F.R.L., KRUSEMAN, A.C.N., POITEVIN, P. & LÉVY, B.I. (1993). Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats. J. Clin. Invest., 92, 1407-1411.
14. KARASU, Ç., DEWHURST, M., STEVENS, E.J. & TOMLINSON, D.R. (1995). Effects of anti-oxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats; comparison with essential fatty acids. Diabetologia, 38, 129-134.
15. KIHARA, M. & LOW, P.A. (1995). Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathy. Exp. Neurol., 132, 180-185.
16. KIHARA, M., SCHMELZER, J.D., PODUSLO, J.F., CURRAN, G.L., NICKANDER, K.K. & LOW, P.A. (1991). Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals. Proc. Natl. Acad. Sci. U.S.A., 88, 6107-6111.
17. KUMARI, K., UMAR, S., BANSAL, V. & SAHIB, M.K. (1991). Monoaminoguanidine inhibits aldose reductase. Biochem. Pharmacol., 41, 1527-1528.
18. LASZLO, F., EVANS, S.M. & WHITTLE, B.J.R. (1995). Aminoguanidine inhibits both constitutive and inducible nitric oxide synthase isoforms in rat intestinal microvasculature in vivo. Eur. J. Pharmacol., 272, 169-175.
19. LOW, P.A. & NICKANDER, K.K. (1991). Oxygen free radical effects in sciatic nerve in experimental diabetes. Diabetes, 40, 873-877.
20. LOW, P.A. & TUCK, R.R. (1984). Effects of changes of blood pressure, respiratory acidosis and hypoxia on blood flow in the sciatic nerve of the rat. J. Physiol., 347, 513-524.
21. OMAWARI, N., DEWHURST, M. VO, P.A., MAHMOOD, S., STEVENS, E. & TOMLINSON, D.R. (1996). Deficient nitric oxide responsible for reduced nerve blood flow in diabetic rats: effects of L-NAME, L-arginine, sodium nitroprusside and evening primrose oil. Br. J. Pharmacol., 118,
22. PIEPER, G.M. & GARRETT, J.G (1988). Oxygen free radicals abolish endothelium dependent relaxation in diabetic rat aorta. Am. J. Physiol., 255, H825-H833.
23. POSTON, L. & TAYLOR, P.D. (1995). Endothelium-mediated vascular function in insulin-dependent diabetes mellitus. Clin. Sci., 88, 245-255.
24. 14C]iodoantipyrine. Am. J. Physiol., 248, 311-317.
25. STEVENS, E.J., CARRINGTON, A.L. & TOMLINSON, D.R. (1993). Prostacyclin release in experimental diabetes: effects of evening primrose oil. Prostaglandins Leukotriens Essent. Fatty Acids, 49, 699-706.
26. STEVENS, E.J., CARRINGTON, A.L. & TOMLINSON, D.R. (1994a). Nerve ischaemia in diabetic rats: time-course of development, effect of insulin treatment plus comparison of streptozotocin and BB models. Diabetologia, 37, 43-48.
27. STEVENS, E.J., KALICHMAN, M.W., MIZISIN, A.P., CALCUTT, N.A. & TOMLINSON, D.R. (1994b). Blood flow in nerve and dorsal root ganglia in experimental diabetes, effects of insulin. J. Physiol., 475, 68P.
28. STEVENS, E.J. & TOMLINSON, D.R. (1995). Effects of endothelin receptor antagonism with bosentan on peripheral nerve function in experimental diabetes. Br. J. Pharmacol., 115, 373-379.
29. TAKEUCHI, M. & LOW, P.A. (1987). Dynamic peripheral nerve metabolic and vascular responses to exsanguination. Am. J. Physiol., 253, E349-E353.
30. TESFAYE, S., MALIK, R. & WARD, J.D. (1994). Vascular factors in diabetic neuropathy. Diabetologia, 37, 847-854.
31. THOMAS, P.K. & TOMLINSON, D.R. (1992). Diabetic and hypoglycaemic neuropathy. In Peripheral Neuropathy. ed. Dyck, P.J., Thomas, P.K., Griffin, J.W., Low, P.A. & Poduslo, J.F. pp. 1219-1250. Philadelphia: W.B. Saunders Co.
32. TILTON, R.G., CHANG, K., HASAN, K.S., SMITH, S.R., PETRASH, J.M., MISKO, T.P., MOORE, W.M., CURRIE, M.G., CORBETT, J.A., MCDANIEL, M.L. & WILLIAMSON, J.R. (1993). Prevention of diabetic vascular dysfunction by guanidines: Inhibition of nitric oxide synthesis versus advanced glycation end-product formation. Diabetes, 42, 221-232.
33. TUCK, R.R., SCHMELZER, J.D. & LOW, P.A. (1984). Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain, 107, 935-950.
34. WARD, K.K., LOW, P.A., SCHMELZER, J.D. & ZOCHODNE, D.W. (1989). Prostacyclin and noradrenaline in peripheral nerve of chronic experimental diabetes in rats. Brain, 112, 197-208.
35. WU, C.-C., CHEN, S.-J., SZABO, C., THIEMERMANN, C. & VANE, J.R. (1995). Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br. J. Pharmacol., 114, 1666-1672.
36. YAGIHASHI, S., KAMIJO, M., BABA, M., YAGIHAHI, N. & NAGAI, K. (1992). Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats. Diabetes, 41, 47-52.
37. YAGIHASHI, S., KUDO, K. & NISHIHIRA, M. (1979). Peripheral nerve structures of experimental diabetes rats and the effect of insulin treatment. J. Exp. Med., 127, 35-44.